Xiuqing Wang

Xiuqing Wang

Auto-generated profile, based on publicly available information

Xiuqing Wang

College of Laboratory Medicine, Ningxia Medical University, Yinchuan 750004, China; Ningxia Key Laboratory of Clinical Pathogenic Microorganisms, Ningxia Medical University, Yinchuan 750004, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2021 in Oncology Letters
Verified
Journal Article
Open access
PDF file
TYTingting Yang
Tingting Yang
JLJun Li
Jun Li
QJQinqin Jia
Qinqin Jia
SZShisheng Zhan
Shisheng Zhan
QZQiannan Zhang
Qiannan Zhang
XWXiuqing Wang
Xiuqing Wang
In 2018, there were 18.1 million new cancer cases and 9.6 million cancer‑related deaths worldwide, among which the incidence rate of lung cancer (11.6%) and fatality rate (18.4%) both ranked first. The antimicrobial peptide LL‑37 is an important component of the natural immune system and possesses several biological properties, including antibacterial, antiviral and anticancer effects. The antimicrobial peptide 17BIPHE2, the shortest synthetic peptide derivative of LL‑37, exhibits biological activities similar to those of LL‑37. The objective of the present study was to investigate the mechanism of action of exogenous 17BIPHE2 against lung cancer cells. The human lung adenocarcinoma cell line A549 was treated with 17BIPHE2. Changes in cell proliferation, migration, invasion, mitochondrial membrane potential (ΔΨm), and the levels of reactive oxygen species (ROS), Ca2+ and apoptosis‑related proteins, including BAX, BCL‑2 and ERK, were detected using flow cytometry, transmission electron microscopy and western blotting. The results showed that 17BIPHE2 significantly increased the apoptosis rate of A549 cells and elevated BAX expression, ERK phosphorylation, and ROS and Ca2+ levels, but decreased the expression of BCL‑2, ERK and Ki67. In addition, the peptide reduced ΔΨm and the cell migration ability of A549 cells and inhibited tumor growth. ERK inhibition significantly attenuated the anticancer effect of 17BIPHE2. The present observations suggested that 17BIPHE2 can effectively inhibit cancer cells by regulating the ERK signaling pathway.

1 March 2012 in Experimental Biology and Medicine
Verified
Journal Article
Closed access
XWXiuqing Wang
Xiuqing Wang
MZMingxing Zhu
Mingxing Zhu
AZAijun Zhang
Aijun Zhang
FYFengqin Yang
Fengqin Yang
PCPuyan Chen
Puyan Chen
The hybrid peptide CA(1–7)–M(2–12) gene was designed according to the N-terminal 1–7 amino acid sequence of the antimicrobial peptide cecropin A (CA) and the N-terminal 2–12 amino acid sequence of maganin (M) and synthesized using Pichia pastoris preferred codons. The gene was cloned into pPICZ αA and transformed into the P. pastoris recipient bacterium SMD1168, regulated by the alcohol oxidase (AOX). Expression of the cecA-mag hybrid antimicrobial peptide (MW, 1.9 kDa) revealed broad-spectrum antibiotic activity and to the ability to inhibit growth of most G− and G+ bacteria. Three mutants of cecA-mag were designed and synthesized by recombination polymerase chain reaction site-directed mutagenesis to investigate the relationship between the structure and function of this antimicrobial peptide. The inhibition titers of these mutants against Staphylococcus aureus were evaluated using the agar diffusion method. Under the conditions of the same concentration and volume, the bacteriostatic diameters of three cecA-mag mutants were 1.2, 1.2 and 1.5 times, respectively, compared with the diameters of wild-type cecA-mag.

12 August 2015 in Biotechnology and Applied Biochemistry
Verified
Journal Article
Closed access
PDF file
LYLongmei Yu
Longmei Yu
MZMingxing Zhu
Mingxing Zhu
ELErqiang Liu
Erqiang Liu
TYTiantian Yang
Tiantian Yang
XCXiangjun Chen
Xiangjun Chen
XWXiuqing Wang
Xiuqing Wang

26 April 2025 in Chemico-Biological Interactions
Verified
Journal Article
Open access
WZWenjing Zhang
Wenjing Zhang
FMFei Ma
Fei Ma
XSXuhong Su
Xuhong Su
MZMingxing Zhu
Mingxing Zhu
XWXiuqing Wang
Xiuqing Wang
To elucidate the inhibitory mechanism of antimicrobial peptide WK-13-3D on triple-negative breast cancer (TNBC) by targeting the binding immunoglobulin protein (BiP), a key endoplasmic reticulum (ER) chaperone regulating unfolded protein response and tumor survival. TNBC cell lines (MDA-MB-231 and MDA-MB-468) were treated with WK-13-3D to assess proliferation, migration, invasion, and apoptosis. Pull-down assays identified interacting proteins, and Western blotting (WB) analyzed alterations in BiP, PERK, eIF2α, p-eIF2α, Caspase3, Cleaved-Caspase3, Bax, LC3, P62, AKT, p-AKT, mTOR, and p-mTOR. Transmission electron microscopy examined intracellular structures, while qPCR measured BiP mRNA levels. The effects of WK-13-3D on BiP ubiquitination were explored via co-immunoprecipitation (Co-IP). Animal tumor models were used to confirm the inhibitory effects, with BiP and Ki67 (a nuclear proliferation marker indicating actively dividing tumor cells) expression analyzed by immunohistochemistry (IHC). WK-13-3D inhibited TNBC cell proliferation, migration, and invasion, while promoting apoptosis. Pull-down experiments identified 268 interacting proteins, with BiP being the most frequent. Databases (TIMER and TCGA) showed high BiP expression in breast cancer, associated with poor prognosis. WB assays revealed that WK-13-3D activated ER stress-induced apoptosis and autophagy via BiP. Co-IP demonstrated that WK-13-3D mediated BiP ubiquitination at sites 352 and 547 through K6 and K29 chains. IHC analysis further confirmed decreased Ki67 levels in WK-13-3D-treated tumors, reflecting suppressed proliferative activity. Animal experiments confirmed tumor growth inhibition. WK-13-3D promotes apoptosis, autophagy and Ubiquitination in TNBC by modulating BiP.

1 January 2024 in Technology in Cancer Research & Treatment
Verified
Journal Article
Open access
FMFei Ma
Fei Ma
JSJinxuan Song
Jinxuan Song
MHMin He
Min He
XWXiuqing Wang
Xiuqing Wang
Purpose: To investigate the inhibitory effect of antimicrobial peptide merecidin on triple-negative breast cancer (TNBC) and the mechanism of inhibiting epithelial-mesenchymal transformation (EMT) by regulating miR-30d-5p/vimentin. Methods: TNBC cell lines (MDA-MB-231, MDA-MB-468) were treated with merecidin to assess proliferation, migration, invasion ability, and EMT. Confocal laser localization was used to examine the role of merecidin and TNBC cells. The relationship between merecidin and miR-30d-5p was determined through RT-qPCR and dual-luciferase reporter gene, and the relationship between merecidin and vimentin was verified through pulling down the experiment. The effects of miR-30d-5p on the migration and invasion ability of TNBC cells were confirmed through scratch and transwell experiments. Vimentin levels, tumor volume, shape, size, and weight were observed in the MDA-MB-231 subcutaneous tumor model in nude mice. Results: merecidin inhibited the proliferation, migration, invasion, and EMT of TNBC cells. merecidin was primarily located in the cytoplasm of TNBC cells, and the expression of miR-30d-5p was low in TNBC cells. merecidin significantly up-regulated the expression of miR-30d-5p. miR-30d-5p negatively regulated vimentin. merecidin could bind to vimentin in vitro. miR-30d-5p inhibited the migration and invasion ability of TNBC cells, while vimentin promoted their migration and invasion ability. Down-regulation of miR-30d-5p or overexpression of vimentin partially counteracted the inhibitory effects of merecidin on TNBC cell migration, invasion ability, and EMT. In nude mouse tumor models, merecidin significantly suppressed tumor growth. Conclusion: Merecidin effectively blocks the EMT process and inhibits the migration and invasion of TNBC cells by regulating miR-30d-5p/vimentin.

4 April 2026 in Antiviral Research
Verified
Journal Article
Closed access
FCFengxue Chai
Fengxue Chai
TKTakele Adugna Kassegn
Takele Adugna Kassegn
JDJunzheng Du
Junzheng Du
QNQingli Niu
Qingli Niu
JYJifei Yang
Jifei Yang
ZTZhancheng Tian
Zhancheng Tian